Huang 2020.
Study name | A multicenter randomized trial of personalized acupuncture, fixed acupuncture, letrozole, and placebo letrozole on live birth in infertile women with polycystic ovary syndrome |
Methods | The trial is designed as an assessor‐blinded RCT |
Participants | A total of 1100 infertile women with PCOS will be recruited from 28 hospitals |
Interventions | Participants will be randomly allocated to 4 groups: personalised acupuncture, fixed acupuncture, letrozole, or placebo letrozole. They will receive treatment for 16 weeks. |
Outcomes | Primary outcome: live birth Secondary outcomes: ovulation rate, conception rate, pregnancy rate, pregnancy loss rate, changes in hormonal and metabolic parameters, and changes in quality of life scores Adverse events will be recorded throughout the trial. |
Starting date | August 2018 |
Contact information | Jie Qiao, jie.qiao@263.net |
Notes |